Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Topotecan in mantle cell lymph...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Topotecan in mantle cell lymphoma - A 21 day continuous infusion regimen may have advantages over intermittent therapy.
Bibliographic Details
Main Authors:
Poynton, C
,
Maughan, T
,
Hasan, F
,
Falk, S
,
Shelley, M
,
Smith, P
Format:
Journal article
Published:
2001
Holdings
Description
Similar Items
Staff View
Similar Items
Clinical impact of diagnostic discrepancies identified by central pathological review of lymphomas - A report of the All Wales Lymphoma Pathology Group
by: Dojcinov, S, et al.
Published: (2001)
Mantle Cell Lymphoma Masquerading as obstructive sleep apnoea
by: Ishak, Noor Liza, et al.
Published: (2022)
Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya
by: Mugo, PM, et al.
Published: (2014)
A novel calcium infusion regimen after parathyroidectomy for renal hyperparathyroidism
by: Tan, Jih Huei, et al.
Published: (2017)
The clinical impact of expert pathological review on lymphoma management: a regional experience.
by: Lester, J, et al.
Published: (2003)